Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

The Effect of Laughter Yoga Applied to Nursing Students on Exam Anxiety and Spirituality

NCT06943430 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-02-24
Last updated
2025-12-03

Condition(s) studied

Exam StressAnxietySpirituality

Investigational drug(s) / intervention(s)

laughter yoga

laughter yoga: Participants in the intervention group received laughter yoga sessions twice a week for a total of four weeks.

Study summary

This study is planned as a randomized controlled trial to determine the effect of laughter yoga on the exam anxiety and spirituality levels of nursing students. The research will be conducted with 100 second-year nursing students between 04.2025 and 06.2025. Students who meet the inclusion criteria will be randomized and divided into two groups: the experimental group (n=36) and the control group (n=36). All participating students will be administered the "Demographic Characteristics Form," "Exam Anxiety Scale," and "Spirituality Scale" (pre-test).

The experimental group will undergo laughter yoga sessions twice a week for 4 weeks, totaling 8 sessions.

The control group will only complete the "Demographic Characteristics Form," "Exam Anxiety Scale," and "Spirituality Scale" (pre-test). No intervention will be applied to the control group.

After the laughter yoga sessions are completed, both the experimental and control groups will complete the "Demographic Characteristics Form," "Exam Anxiety Scale," and "Spirituality Scale" (post-test).

The collected data will be analyzed using SPSS 22 software.

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Being a 2nd-year student in the Nursing Department * Able to speak and understand Turkish * Voluntarily agreeing to participate in the study * No visual or hearing impairments * No history of psychiatric illness * No current or past use of psychotropic medication Exclusion Criteria: * Refusal to participate in the study * Inability to speak or understand Turkish * Diagnosed psychiatric illness and/or use of psychotropic agents * Previous participation in laughter yoga * Physical limitations or respiratory problems preventing yoga practice * Difficulty in performing breathing exercises due to conditions such as septum deviation * Abdominal surgery within the past 6 months Drop-out Criteria: * Failure to attend any of the laughter yoga sessions * Receiving a new diagnosis that contraindicates laughter yoga during the 4-week intervention period

Primary outcome measure(s)

  • Change in exam anxiety levels as measured by the Test Anxiety Scale — Baseline and post-intervention (Week 4)
    Exam anxiety will be assessed using a validated Test Anxiety Scale before and after the 4-week laughter yoga intervention. The mean score difference between pre-test and post-test will be analyzed using paired samples t-test.

Trial sites (1)

FacilityCityRegionStatus
Kirikkale University Kirikkale Turkey
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06943430 on ClinicalTrials.gov ↗ ← All trials in Turkey